|
Robin Gadsby, MA, MEng, MBA, completed a 36-year career at ICI PLC as President North America, ICI Chemicals&Polymers and served as a Director of ICI Americas Inc. for ten years. Mr. Gadsby has a wealth of experience in developing and leading successful specialty and commodity chemicals businesses. He led the strategic work in London that resulted in the acquisition by ICI of the Unilever specialty chemicals businesses which repositioned ICI from being largely a business of disparate bulk commodities to being a higher value added specialty chemicals business. Since leaving ICI, Mr. Gadsby has served as a Director of The Catalyst Group, Venture Biologics LLC, Ricerca LLC and from 2006 as Chairman of Cempra Pharmaceuticals Inc. a new biotechnology drug discovery and development company. Mr. Gadsby has an MA in Natural Sciences and an MEng in Chemical Engineering from the University of Cambridge and an MBA from the University of Chicago. He attended the Advanced Management Program at INSEAD, France. He is a member of the Institute of Chartered Financial Analysts, the New York Academy of Sciences, the American Chemical Society, and the American Institute of Chemical Engineers. | 